What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Giancarlo Pruneri focuses on Breast cancer, Internal medicine, Oncology, Cancer and Pathology.
His research integrates issues of Clinical trial, Randomized controlled trial, Disease, Hazard ratio and Surgical oncology in his study of Breast cancer.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
His work carried out in the field of Oncology brings together such families of science as Survival rate, Estrogen receptor, Progesterone receptor, Tumor-infiltrating lymphocytes and Triple-negative breast cancer.
In the subject of general Cancer, his work in Breast disease is often linked to MEDLINE, thereby combining diverse domains of study.
His Pathology research is multidisciplinary, incorporating elements of Angiogenesis and Neovascularization.
His most cited work include:
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 (1126 citations)
- Resting and activated endothelial cells are increased in the peripheral blood of cancer patients (392 citations)
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type (323 citations)
What are the main themes of his work throughout his whole career to date?
Giancarlo Pruneri mostly deals with Internal medicine, Breast cancer, Oncology, Pathology and Cancer research.
The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine.
His Breast cancer research is included under the broader classification of Cancer.
He studied Oncology and Carcinoma that intersect with Ductal carcinoma.
His research in Pathology intersects with topics in Cyclin D1 and Angiogenesis.
His Cancer research research incorporates themes from Carcinogenesis, Gene, Cancer cell and Gene mutation.
He most often published in these fields:
- Internal medicine (64.52%)
- Breast cancer (56.53%)
- Oncology (51.27%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (64.52%)
- Oncology (51.27%)
- Breast cancer (56.53%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Breast cancer, Cancer research and Cancer.
His work deals with themes such as Stage, Hormone receptor and Chemotherapy, Adjuvant therapy, which intersect with Oncology.
His Chemotherapy study combines topics from a wide range of disciplines, such as Biopsy, Triple-negative breast cancer and Adenocarcinoma.
Giancarlo Pruneri works in the field of Breast cancer, focusing on Estrogen receptor in particular.
The various areas that Giancarlo Pruneri examines in his Cancer research study include Cell, Carcinogenesis, Downregulation and upregulation, Metastasis and Epigenetics.
Particularly relevant to Colorectal cancer is his body of work in Cancer.
Between 2018 and 2021, his most popular works were:
- Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers (170 citations)
- Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade (157 citations)
- ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) (39 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Internal medicine, Breast cancer, Oncology, Cancer research and Disease.
His work in the fields of Breast cancer, such as Estrogen receptor, intersects with other areas such as MEDLINE.
The Oncology study combines topics in areas such as Chemotherapy, Mutation, Tumor-infiltrating lymphocytes, Rituximab and Primary tumor.
His Cancer research study integrates concerns from other disciplines, such as Thyroid cancer, Carcinogenesis, Metastasis, Epigenetics and PTEN.
His Disease research incorporates elements of Cancer and Healthcare system.
His work in the fields of Paclitaxel overlaps with other areas such as Severe acute respiratory syndrome coronavirus 2.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
